Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07594652 · ClinicalTrials.gov registry record · Phase 4
Medication Treatment of ADHD in Pediatric Epilepsy
A Phase 4 study, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 25
- Enrollment target
NCT07594652 is a Phase 4 study that is actively recruiting participants, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 25 participants.
The verdict
NCT07594652, a Phase 4 study, is actively recruiting participants, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 25 participants
- Enrollment target
Study Summary
This is an observational study assessing the usage of stimulant medication for ADHD in the context of pediatric epilepsy.
Interventions
- DRUG methylphenidate hydrochloride (Jornay PM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2026-05 |
| Est. Completion | 2030-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07594652
The ClinicalTrials.gov registry entry for NCT07594652 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which methylphenidate hydrochloride (Jornay PM) is the first listed.
NCT07594652 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07594652 about?
NCT07594652 is a clinical study titled "Medication Treatment of ADHD in Pediatric Epilepsy". This is an observational study assessing the usage of stimulant medication for ADHD in the context of pediatric epilepsy.
What is the current status of trial NCT07594652?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2026-05. Estimated completion is 2030-12.
What interventions are being tested in trial NCT07594652?
The interventions under investigation include: methylphenidate hydrochloride (Jornay PM) (DRUG).
Who is sponsoring clinical trial NCT07594652?
This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.